Co-expression vs. co-infection using baculovirus expression vectors in insect cell culture: Benefits and drawbacks

Biotechnology Advances

Volumn 30, Issue 3, 2012, Pages 766-781

  Sokolenko, Stanislav ^a   George, Steve ^a   Wagner, Andreas ^a   Tuladhar, Anup ^a   Andrich, Jonas M S ^a   Aucoin, Marc G ^a  

^a UNIVERSITY OF WATERLOO   (Canada)

Author keywords

Baculovirus; Chaperone; Co expression; Co infection; Cytochrome P450; Heterologous protein; Insect cell; Promoter; Vector; Virus like particle

Indexed keywords

BACULOVIRUS; CHAPERONE; CO-EXPRESSION; CO-INFECTIONS; CYTOCHROME P450; HETEROLOGOUS PROTEINS; INSECT CELLS; PROMOTER; VIRUS-LIKE PARTICLES;

CELL CULTURE; PROTEINS; VECTORS; VIRUSES;

GENE EXPRESSION;

CHAPERONE; MULTIPROTEIN COMPLEX;

CELL ORGANELLE; DISEASE VECTOR; GENE EXPRESSION; INFECTIVITY; MAMMAL; NUMERICAL MODEL; PROTEIN; VIRUS;

ANIMAL; BACULOVIRUS; BIOSYNTHESIS; CELL ENGINEERING; CULTURE TECHNIQUE; CYTOLOGY; GENE EXPRESSION; GENE VECTOR; GENETICS; INSECT; MIXED INFECTION; PROTEIN PROCESSING; REVIEW;

ANIMALS; BACULOVIRIDAE; CELL CULTURE TECHNIQUES; CELL ENGINEERING; COINFECTION; GENE EXPRESSION; GENETIC VECTORS; INSECTS; MOLECULAR CHAPERONES; MULTIPROTEIN COMPLEXES; PROTEIN PROCESSING, POST-TRANSLATIONAL;

HEXAPODA; MAMMALIA;

EID: 84857506974     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2012.01.009     Document Type: Review

References (218)

1. Ailor E., Betenbaugh M.J. Overexpression of a cytosolic chaperone to improve solubility and secretion of a recombinant IgG protein in insect cells. Biotechnol Bioeng 1998, 58:196-203.
2. Alessi D.R., Saito Y., Campbell D.G., Cohen P., Sithanandam G., Rapp U., et al. Identification of the sites in MAP kinase kinase-1 phosphorylated by p74raf-1. EMBO J 1994, 13:1610-1619.
3. Aucoin M.G., Perrier M., Kamen A.A. Improving AAV vector yield in insect cells by modulating the temperature after infection. Biotechnol Bioeng 2007, 97:1501-1509.
4. Aucoin M.G., Mena J.A., Kamen A.A. Bioprocessing of baculovirus vectors: a review. Curr Gene Ther 2010, 10:174-186.
5. Aucoin M.G., Perrier M., Kamen A.A. Production of adeno-associated viral vectors in insect cells using triple infection: optimization of baculovirus concentration ratios. Biotechnol Bioeng 2006, 95:1081-1092.
6. Aumiller J.J., Hollister J.R., Jarvis D.L. A transgenic insect cell line engineered to produce CMP-sialic acid and sialylated glycoproteins. Glycobiology 2003, 13:497-507.
7. Ayres M.D., Howard S.C., Kuzio J., Lopez-Ferber M., Possee R.D. The complete DNA sequence of Autographa californica nuclear polyhedrosis virus. Virology 1994, 202:586-605.
8. Bakos E., Evers R., Szakacs G., Tusnady G.E., Welker E., Szabo K., et al. Functional multidrug resistance protein (MRP1) lacking the N-terminal transmembrane domain. J Biol Chem 1998, 273:32167-32175.
9. Bansal G.P., Hatfield J.A., Dunn F.E., Kramer A.A., Brady F., Riggin C.H., et al. Candidate recombinant vaccine for human B19 parvovirus. J Infect Dis 1993, 167:1034-1044.
10. Belyaev A.S., Hails R.S., Roy P. High-level expression of five foreign genes by a single recombinant baculovirus. Gene 1995, 156:229-233.
11. Belyaev A.S., Roy P. Development of baculovirus triple and quadruple expression vectors: co-expression of three or four bluetongue virus proteins and the synthesis of bluetongue virus-like particles in insect cells. Nucleic Acids Res 1993, 21:1219-1223.
12. Bès C., Cerutti M., Briant-Longuet L., Bresson D., Peraldi-Roux S., Pugnière M., et al. The chimeric mouse-human anti-CD4 Fab 13B8.2 expressed in baculovirus inhibits both antigen presentation and HIV-1 promoter. Human Antibody 2001, 10:67-76.
13. Berger I., Fitzgerald D.J., Richmond T.J. Baculovirus expression system for heterologous multiprotein complexes. Nat Biotechnol 2004, 22:1583-1587.
14. Betenbaugh M., Yu M., Kuehl K., White J., Pennock D., Spik K., et al. Nucleocapsid- and virus-like particles assemble in cells infected with recombinant baculoviruses or vaccinia viruses expressing the M and the S segments of Hantaan virus. Virus Res 1995, 38:111-124.
15. Blissard G.W., Kogan P.H., Wei R., Rohrmann G.F. A synthetic early promoter from a baculovirus: roles of the TATA box and conserved start site CAGT sequence in basal levels of transcription. Virology 1992, 190:783-793.
16. Bonning B.C., Roelvink P.W., Vlak J.M., Possee R.D., Hammock B.D. Superior expression of juvenile hormone esterase and beta-galactosidase from the basic protein promoter of Autographa californica nuclear polyhedrosis virus compared to the p10 protein and polyhedrin promoters. J Gen Virol 1994, 75:1551-1556.
17. Brautigam S., Snezhkow E., Bishop D.H.L. Formation of poliovirus-like particles by recombinant baculoviruses expressing the individual VP0, VP3, and VP1 proteins by comparison to particles derived from the expressed poliovirus polyprotein. Virology 1993, 192:512-524.
18. Bright R.A., Carter D.M., Daniluk S., Toapanta F.R., Ahmad A., Gavrilov V., et al. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin. Vaccine 2007, 25:3871-3878.
19. Brown C.S., Van Lent J.W.M., Vlak J.M., Spaan W.J.M. Assembly of empty capsids by using baculovirus recombinants expressing human parvovirus B19 structural proteins. J Virol 1991, 65:2702-2706.
20. Buonaguro L., Buonaguro F.M., Tornesello M.L., Mantas D., Beth-Giraldo E., Wagner R., et al. High efficient production of Pr55(gag) virus-like particles expressing multiple HIV-1 epitopes, including a gp120 protein derived from an Ugandan HIV-1 isolate of subtype A. Antivir Res 2001, 49:35-47.
21. Buonaguro L., Tornesello M.L., Tagliamonte M., Gallo R.C., Wang L.X., Kamin-Lewis R., et al. Baculovirus-derived human immunodeficiency virus type 1 virus-like particles activate dendritic cells and induce ex vivo T-cell responses. J Virol 2006, 80:9134-9143.
22. Bustin S.A. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 2000, 25:169-193.
23. Bustin S.A. Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. J Mol Endocrinol 2002, 29:23-39.
24. Chaabihi H., Ogliastro M.H., Martin M., Giraud C., Devauchelle G., Cerutti M. Competition between baculovirus polyhedrin and p10 gene expression during infection of insect cells. J Virol 1993, 67:2664-2671.
25. Chambers S.P., Austen D.A., Fulghum J.R., Kim W.M. High-throughput screening for soluble recombinant expressed kinases in Escherichia coli and insect cells. Protein Expr Purif 2004, 36:40-47.
26. Chazenbalk G.D., Rapoport B. Expression of the extracellular domain of the thyrotropin receptor in the baculovirus system using a promoter active earlier than the polyhedrin promoter. Implications for the expression of functional highly glycosylated proteins. J Biol Chem 1995, 270:1543-1549.
27. Chen L., Buters J.T.M., Hardwick J.P., Tamura S., Penman B.W., Gonzales F.J., et al. Coexpression of cytochrome P4502A6 and human NADPH-P450 oxidoreductase in the baculovirus system. Drug Metab Dispos 1997, 25:399-405.
28. Chico E., Jager V. Perfusion culture of baculovirus-infected BTI-Tn-5B1-4 insect cells: a method to restore cell-specific beta-trace glycoprotein productivity at high cell density. Biotechnol Bioeng 2000, 70:574-586.
29. Chung Y.C., Huang J., Lai C.W., Sheng H.C., Shih S.R., Ho M., et al. Expression, purification and characterization of enterovirus-71 virus-like particles. World J Gastroenterol 2006, 12:921.
30. Conner M.E., Zarley C.D., Hu B., Parsons S., Drabinski D., Greiner S., et al. Virus-like particles as a rotavirus subunit vaccine. J Infect Dis 1996, 174:S88-S92.
31. Crawford S.E., Labbe M., Cohen J., Burroughs M.H., Zhou Y., Estes M.K. Characterization of virus-like particles produced by the expression of rotavirus capsid proteins in insect cells. J Virol 1994, 68:5945-5952.
32. Cruz P.E., Peixoto C.C., Devos K., Moreira J.L., Saman E., Carrondo M.J.T. Characterization and downstream processing of HIV-1 core and virus-like-particles produced in serum free medium. Enzyme Microb Tech 2000, 26:61-70.
33. Dalal N.G., Bentley W.E., Cha H.J. Facile monitoring of baculovirus infection for foreign protein expression under very late polyedrin promoter using green fluorescent protein reporter under early-to-late promoter. Biochem Eng J 2005, 24:27-30.
34. Dalal N.G., Cha H.J., Kramer S.F., Kostov Y., Rao G., Bentley W.E. Rapid non-invasive monitoring of baculovirus infection for insect larvae using green fluorescent protein reporter under early-to-late promoter and a GFP-specific optical probe. Process Biochem 2006, 41:947-950.
35. de Gooijer C.D., van Lier F.L.J., van den End E.J., Vlak J.M., Tramper J. A model for baculovirus production with continuous insect cell cultures. Appl Microbiol Biot 1989, 30:497-501.
36. de Gooijer C.D., Koken R.H., van Lier F.L., Kool M., Vlak J.M., Tramper J. A structured dynamic model for the baculovirus infection process in insect-cell reactor configurations. Biotechnol Bioeng 1992, 40:537-548.
37. Dee K.U., Shuler M.L. A mathematical model of the trafficking of acid-dependent enveloped viruses: application to the binding, uptake, and nuclear accumulation of baculovirus. Biotechnol Bioeng 1997, 54:468-490.
38. Deml L., Kratochwil G., Osterrieder N., Knuchel R., Wolf H., Wagner R. Increased incorporation of chimeric human immunodeficiency virus type 1 gp120 proteins into Pr55gag virus-like particles by an Epstein-Barr virus gp220/350-derived transmembrane domain. Virology 1997, 235:10-25.
39. Dent P., Chow Y.H., Wu J., Morrison D.K., Jove R., Sturgill T.W. Expression, purification and characterization of recombinant mitogen-activated protein kinase kinases. Biochem J 1994, 303:105-112.
40. Ding H., Griesel C., Nimtz M., Conradt H.S., Weich H.A., Jager V. Molecular cloning, expression, purification, and characterization of soluble full-length, human interleukin-3 with a baculovirus-insect cell expression system. Protein Expr Purif 2003, 31:34-41.
41. Dreker L., Schwarz J., Reichel W. Hilschmann N. Hoppe Seylers Z Physiol Chem 1976, 357:1515-1540.
42. Dubel S. Recombinant therapeutic antibodies. Appl Microbiol Biotechnol 2007, 74:723-729.
43. Duffy S.P., Becker E.M., Whittome B.H., Lucarotti C.J., Levin D.B. In vivo replication kinetics and transcription patterns of the nucleopolyhedrovirus (NeabNPV) of the balsam fir sawfly, Neodiprion abietis. J Gen Virol 2007, 88:1945-1951.
44. Elias C.B., Jardin B., Kamen A.A. Recombinant protein production in large-scale agitated bioreactors using the baculovirus expression vector system. Methods Mol Biol 2007, 388:225-246.
45. Fink A.L. Chaperone-mediated protein folding. Physiol Rev 1999, 79:425-449.
46. Fitzgerald D.J., Berger P., Schaffitzel C., Yamada K., Richmond T.J., Berger I. Protein complex expression by using multigene baculoviral vectors. Nat Methods 2006, 3:1021-1032.
47. Fitzgerald D.J., Schaffitzel C., Berger P., Wellinger R., Bieniossek C., Richmond T.J., et al. Multiprotein expression strategy for structural biology of eukaryotic complexes. Structure 2007, 15:275-279.
48. Fourneau J.M., Cohen H., van Endert P.M. A chaperone-assisted high yield system for the production of HLA-DR4 tetramers in insect cells. J Immunol Methods 2004, 285:253-264.
49. French T.J., Marshall J.J.A., Roy P. Assembly of double-shelled, viruslike particles of bluetongue virus by the simultaneous expression of four structural proteins. J Virol 1990, 64:5695-5700.
50. French T.J., Roy P. Synthesis of bluetongue virus (BTV) corelike particles by a recombinant baculovirus expressing the two major structural core proteins of BTV. J Virol 1990, 64:1530-1536.
51. Gallo-Ramirez L.E., Ramirez O.T., Palomares L.A. Intracellular localization of adeno-associated viral proteins expressed in insect cells. Biotechnol Prog 2011, 27:483-493.
52. Gao M., Cui H.R., Loe D.W., Grant C.E., Almquist K.C., Cole S.P.C., et al. Comparison of the functional characteristics of the nucleotide binding domains of multidrug resistance protein 1. J Biol Chem 2000, 275:13098-13108.
53. Gao M., Loe D.W., Grant C.E., Cole S.P.C., Deeley R.G. Reconstitution of ATP-dependent leukotriene C4 transport by co-expression of both half-molecules of human multidrug resistance protein in insect cells. J Biol Chem 1996, 271:27782-27787.
54. Garcea R.L., Gissmann L. Virus-like particles as vaccines and vessels for the delivery of small molecules. Curr Opin Biotechnol 2004, 15:513-517.
55. Geisler C., Jarvis D.L. Identification of genes encoding N-glycan processing beta-N-acetylglucosaminidases in Trichoplusia ni and Bombyx mori: implications for glycoengineering of baculovirus expression systems. Biotechnol Prog 2010, 26:34-44.
56. Gotoh T., Ando N., Kikuchi K. Re-infection profile of baculoviruses to Sf9 insect cells that have already been infected: virus binding and recombinant protein production. J Chem Eng Jpn 2008, 41:804-808.
57. Gotoh T., Chiba K., Kikuchi K. Probabilistic characterization for baculovirus-infected insect cells destined to synthesize progeny viruses and recombinant protein and to die. J Chem Eng Japan 2004, 37:1357-1366.
58. Gout I., Dhand R., Panayotou G., Fry M.J., Hiles I., Otsu M., et al. Expression and characterization of the p85 subunit of the phosphatidylinositol 3-kinase complex and a related p85 beta protein by using the baculovirus expression system. Biochem J 1992, 288(Pt 2):395-405.
59. Grabherr R., Ernst W., Doblhoff-Dier O., Sara M., Katinger H. Expression of foreign proteins on the surface of Autographa californica nuclear polyhedrosis virus. Biotechniques 1997, 22:730-735.
60. Grant C.E., Gao M., DeGorter M.K., Cole S.P., Deeley R.G. Structural determinants of substrate specificity differences between human multidrug resistance protein (MRP) 1 (ABCC1) and MRP3 (ABCC3). Drug Metab Dispos 2008, 36:2571-2581.
61. Guarino L.A., Gonzalez M.A., Summers M.D. Complete sequence and enhancer function of the homologous DNA regions of Autographa californica nuclear polyhedrosis virus. J Virol 1986, 60:224-229.
62. Guo L., Lu X., Kang S., Chen C., Compans R.W., Yao Q. Enhancement of mucosal immune responses by chimeric influenza HA/SHIV virus-like particles. Virology 2003, 313:502-513.
63. Hartl F.U. Molecular chaperones in cellular protein folding. Nature 1996, 381:571-579.
64. Hassan N.J., Gul S., Flett F., Hollingsworth E., Dunne A.A., Emmons A.J., et al. Development of an insect-cell-based assay for detection of kinase inhibition using NF-kappaB-inducing kinase as a paradigm. Biochem J 2009, 419:65-73.
65. Higgins M.K., Demir M., Tate C.G. Calnexin co-expression and the use of weaker promoters increase the expression of correctly assembled Shaker potassium channel in insect cells. Biochim Biophys Acta 2003, 1610:124-132.
66. Hill D.R., Aumiller J.J., Shi X., Jarvis D.L. Isolation and analysis of a baculovirus vector that supports recombinant glycoprotein sialylation by SfSWT-1 cells cultured in serum-free medium. Biotechnol Bioeng 2006, 95:37-47.
67. Hill-Perkins M.S., Possee R.D. A baculovirus expression vector derived from the basic protein promoter of Autographa californica nuclear polyhedrosis virus. J Gen Virol 1990, 71:971-976.
68. Hitchman R.B., Possee R.D., Crombie A.T., Chambers A., Ho K., Siaterli E., et al. Genetic modification of a baculovirus vector for increased expression in insect cells. Cell Biol Toxicol 2010, 26:57-68.
69. Ho Y., Lin P., Liu C.Y.Y., Lee S., Chao Y. Assembly of human severe acute respiratory syndrome coronavirus-like particles. Biochem Biophys Res Commun 2004, 318:833-838.
70. Hollister J., Grabenhorst E., Nimtz M., Conradt H., Jarvis D.L. Engineering the protein N-glycosylation pathway in insect cells for production of biantennary, complex N-glycans. Biochemistry 2002, 41:15093-15104.
71. Hollister J.R., Shaper J.H., Jarvis D.L. Stable expression of mammalian beta 1,4-galactosyltransferase extends the N-glycosylation pathway in insect cells. Glycobiology 1998, 8:473-480.
72. Hong S.M., Yamashita J., Mitsunobu H., Uchino K., Kobayashi I., Sezutsu H., et al. Efficient soluble protein production on transgenic silkworms expressing cytoplasmic chaperones. Appl Microbiol Biotechnol 2010, 87:2147-2156.
73. Hoque M., Shimizu N., Ishizu K., Yajima H., Arisaka F., Suzuki K., et al. Chimeric virus-like particle formation of adeno-associated virus. Biochem Biophys Res Commun 1999, 266:371-376.
74. Hsu Ta, Betenbaugh M.J. Coexpression of molecular chaperone BiP improves immunoglobulin solubility and IgG secretion from Trichoplusia ni insect cells. Biotechnol Prog 1997, 13:96-104.
75. Hsu T.A., Eiden J.J., Bourgarel P., Meo T., Betenbaugh M.J. Effects of co-expressing chaperone BiP on functional antibody production in the baculovirus system. Protein Expression Purif. 1994, 5:595-603.
76. Hsu T.A., Watson S., Eiden J.J., Betenbaugh M.J. Rescue of immunoglobulins from insolubility is facilitated by PDI in the baculovirus expression system. Protein Expr Purif 1996, 7:281-288.
77. Hu Y., Bentley W.E. Effect of MOI ratio on the composition and yield of chimeric infectious bursal disease virus-like particles by baculovirus co-infection: deterministic predictions and experimental results. Biotechnol Bioeng 2001, 75:104-119.
78. Hu Y., Bentley W.E. A kinetic and statistical-thermodynamic model for baculovirus infection and virus-like particle assembly in suspended insect cells. Chem Eng Sci 2000, 55:3991-4008.
79. Hu Y., Hsu J.T., Huang J., Ho M., Ho Y. Formation of enterovirus-like particle aggregates by recombinant baculoviruses co-expressing P1 and 3CD in insect cells. Biotechnol Lett 2003, 25:919-925.
80. Hyatt A.D., Zhao Y., Roy P. Release of bluetongue virus-like particles from insect cells is mediated by BTV nonstructural protein NS3/NS3A. Virology 1993, 193:592-603.
81. Idriss H., Urquidi V., Basavappa S. Selective modulation of P-glycoprotein's ATPase and anion efflux regulation activities with PKC alpha and PKC epsilon in Sf9 cells. Cancer Chemother Pharmacol 2000, 46:287-292.
82. Inoue T., Kawano M., Takahashi R., Tsukamoto H., Enomoto T., Imai T., et al. Engineering of SV40-based nano-capsules for delivery of heterologous proteins as fusions with the minor capsid proteins VP2/3. J Biotechnol 2008, 134:181-192.
83. Ishiyama S., Ikeda M. High-level expression and improved folding of proteins by using the vp39 late promoter enhanced with homologous DNA regions. Biotechnol Lett 2010, 32:1637-1647.
84. Iwanaga M., Takaya K., Katsuma S., Ote M., Tanaka S., Kamita S.G., et al. Expression profiling of baculovirus genes in permissive and nonpermissive cell lines. Biochem Biophys Res Commun 2004, 323:599-614.
85. Jang J.D., Sanderson C.S., Chan L.C.L., Barford J.P., Reid S. Structured modeling of recombinant protein production in batch and fed-batch culture of baculovirus-infected insect cells. Cytotechnology 2000, 34:71-82.
86. Jarvis D.L., Finn E.E. Modifying the insect cell N-glycosylation pathway with immediate early baculovirus expression vectors. Nat Biotechnol 1996, 14:1288-1292.
87. Jarvis D.L., Fleming J.A., Kovacs G.R., Summers M.D., Guarino L.A. Use of early baculovirus promoters for continuous expression and efficient processing of foreign gene products in stably transformed lepidopteran cells. Nat Biotechnol 1990, 8:950-955.
88. Jarvis D.L., Summers M.D. Glycosylation and secretion of human tissue plasminogen activator in recombinant baculovirus-infected insect cells. Mol Cell Biol 1989, 9:214-223.
89. Jarvis D.L., Weinkauf C., Guarino L.A. Immediate-early baculovirus vectors for foreign gene expression in transformed or infected insect cells. Protein Expr Purif 1996, 8:191-203.
90. Jiang S.S., Chang I.S., Huang L.W., Chen P.C., Wen C.C., Liu S.C., et al. Temporal transcription program of recombinant Autographa californica multiple nucleopolyhedrosis virus. J Virol 2006, 80:8989-8999.
91. Just T., Burgwald H., Broe M.K. Flow cytometric detection of EBV (EBER snRNA) using peptide nucleic acid probes. J Virol Methods 1998, 73:163-174.
92. Kaba S.A., Salcedo A.M., Wafula P.O., Vlak J.M., van Oers M.M. Development of a chitinase and v-cathepsin negative bacmid for improved integrity of secreted recombinant proteins. J Virol Methods 2004, 122:113-118.
93. Kadwell S.H., Hardwicke P.I. Production of baculovirus-expressed recombinant proteins in wave bioreactors. Methods Mol Biol 2007, 388:247-266.
94. Kajigaya S., Fujii H., Field A., Anderson S., Rosenfeld S., Anderson L.J., et al. Self-assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions. Proc Natl Acad Sci USA 1991, 88:4646-4650.
95. Kamen A.A., Bedard C., Tom R., Perret S., Jardin B. On-line monitoring of respiration in recombinant-baculovirus infected and uninfected insect cell bioreactor cultures. Biotechnol Bioeng 1996, 50:36-48.
96. Kang S.M., Compans R.W. Enhancement of mucosal immunization with virus-like particles of simian immunodeficiency virus. J Virol 2003, 77:3615-3623.
97. Kang S.M., Quan F.S., Huang C., Guo L., Ye L., Yang C., et al. Modified HIV envelope proteins with enhanced binding to neutralizing monoclonal antibodies. Virology 2005, 331:20-32.
98. Kang S.M., Yoo D.G., Lipatov A.S., Song J.M., Davis C.T., Quan F.S., et al. Induction of long-term protective immune responses by influenza H5N1 virus-like particles. PLoS One 2009, 4:e4667.
99. Kato T., Murata T., Usui T., Park E.Y. Improvement of the production of GFPuv-beta1,3-N-acetylglucosaminyltransferase 2 fusion protein using a molecular chaperone-assisted insect-cell-based expression system. Biotechnol Bioeng 2005, 89:424-433.
100. Kirnbauer R., Taub J., Greenstone H., Roden R., Durst M., Gissmann L., et al. Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles. J Virol 1993, 67:6929-6936.
101. Klejman A., Schreiner S.J., Nieborowska-Skorska M., Slupianek A., Wilson M., Smithgall T.E., et al. The Src family kinase Hck couples BCR/ABL to STAT5 activation in myeloid leukemia cells. EMBO J 2002, 21:5766-5774.
102. Kojima K., Hayakawa T., Asano S., Bando H. Tandem repetition of baculovirus ie1 promoter results in upregulation of transcription. Arch Virol 2001, 146:1407-1414.
103. Kosukegawa A., Arisaka F., Takayama M., Yajima H., Kaidow A., Handa H. Purification and characterization of virus-like particles and pentamers produced by the expression of SV40 capsid proteins in insect cells. Biochim Biophys Acta 1996, 1290:37-45.
104. Krammer F., Schinko T., Messner P., Palmberger D., Ferko B., Grabherr R. Influenza virus-like particles as an antigen-carrier platform for the ESAT-6 epitope of Mycobacterium tuberculosis. J Virol Methods 2010, 167:17-22.
105. Kut E., Rasschaert D. Assembly of Marek's disease virus (MDV) capsids using recombinant baculoviruses expressing MDV capsid proteins. J Gen Virol 2004, 85:769-774.
106. Labbe M., Charpilienne A., Crawford S.E., Estes M.K., Cohen J. Expression of rotavirus VP2 produces empty corelike particles. J Virol 1991, 65:2946-2952.
107. Langereis M.A., Rosas-Acosta G., Mulder K., Wilson V.G. Production of sumoylated proteins using a baculovirus expression system. J Virol Methods 2007, 139:189-194.
108. Latham T., Galarza J.M. Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins. J Virol 2001, 75:6154-6165.
109. Lawrence S.M., Huddleston K.A., Tomiya N., Nguyen N., Lee Y.C., Vann W.F., et al. Cloning and expression of human sialic acid pathway genes to generate CMP-sialic acids in insect cells. Glycoconj J 2001, 18:205-213.
110. Le Blois H., Fayard B., Urakawa T., Roy P. Synthesis and characterization of chimeric particles between epizootic hemorrhagic disease virus and bluetongue virus: functional domains are conserved on the VP3 protein. J Virol 1991, 65:4821-4831.
111. Lee C.A., Kadwell S.H., Kost T.A., Serabjit-Singh C.J. CYP3A4 expressed by insect cells infected with a recombinant baculovirus containing both CYP3A4 and human NADPH-cytochrome P450 reductase is catalytically similar to human liver microsomal CYP3A4. Arch Biochem Biophys 1995, 319:157-167.
112. Lee J.C., Chen H.H., Chao Y.C. Persistent baculovirus infection results from deletion of the apoptotic suppressor gene p35. J Virol 1998, 72:9157-9165.
113. Liang M., Dubel S., Li D., Queitsh I., Li W., Bautz E.K. Baculovirus expression cassette vectors for rapid production of complete human IgG from phage display selected antibody fragments. J Immunol Methods 2001, 247:119-130.
114. Licari P., Bailey J.E. Modeling the population of baculovirus-infected insect cells: optimizing infection strategies for enhanced recombinant protein yields. Biotechnol Bioeng 1992, 39:432-441.
115. Lionberger J.M., Smithgall T.E. The c-Fes protein-tyrosine kinase suppresses cytokine-independent outgrowth of myeloid leukemia cells induced by Bcr-Abl. Cancer Res 2000, 60:1097-1103.
116. Lionberger J.M., Wilson M.B., Smithgall T.E. Transformation of myeloid leukemia cells to cytokine independence by Bcr-Abl is suppressed by kinase-defective Hck. J Biol Chem 2000, 275:18581-18585.
117. Liu X., Zhou W., Zhang P., Xu Q., Hu C., Chen X., et al. Expression of SLAM (CDw150) on Sf9 cell surface using recombinant baculovirus mediates measles virus infection in the nonpermissive cells. Microbes Infect 2005, 7:1235-1245.
118. Loudon P.T., Roy P. Assembly of five bluetongue virus proteins expressed by recombinant baculoviruses: inclusion of the largest protein VP1 in the core and virus-like particles. Virology 1991, 180:798-802.
119. Lu A., Seshagiri S., Miller L.K. Signal sequence and promoter effects on the efficacy of toxin-expressing baculoviruses as biopesticides. Biol Control 1996, 7:320-332.
120. Lu H., Ma J., Liu N., Wang S. Effects of heme precursors on CYP1A2 and POR expression in the baculovirus/Spodoptera frugiperda system. JBR 2010, 24:242-249.
121. Maranga L., Cruz P.E., Aunins J.G., Carrondo M.J. Production of core and virus-like particles with baculovirus infected insect cells. Adv Biochem Eng Biotechnol 2002, 74:183-206.
122. Maranga L., Cunha A., Clemente J., Cruz P., Carrondo M.J.T. Scale-up of virus-like particles production: effects of sparging, agitation and bioreactor scale on cell growth, infection kinetics and productivity. J Biotechnol 2004, 107:55-64.
123. Martinez-Alonso M., Gomez-Sebastian S., Escribano J.M., Saiz J., Ferrer-Miralles N., Villaverde A. DnaK/DnaJ-assisted recombinant protein production in Trichoplusia ni larvae. Appl Microbiol Biotechnol 2010, 86:633-639.
124. Martinez-Alonso M., Toledo-Rubio V., Noad R., Unzueta U., Ferrer-Miralles N., Roy P., et al. Rehosting of bacterial chaperones for high-quality protein production. Appl Environ Microbiol 2009, 75:7850-7854.
125. Meghrous J., Aucoin M.G., Jacob D., Chahal P.S., Arcand N., Kamen A.A. Production of recombinant adeno-associated viral vectors using a baculovirus/insect cell suspension culture system: from shake flasks to a 20-L bioreactor. Biotechnol Prog 2005, 21:154-160.
126. Mena J.A., Aucoin M.G., Montes J., Chahal P.S., Kamen A.A. Improving adeno-associated vector yield in high density insect cell cultures. J Gene Med 2010, 12:157-167.
127. Mena J., Ramirez O.T., Palomares L.A. Population kinetics during simultaneous infection of insect cells with two different recombinant baculoviruses for the production of rotavirus-like particles. BMC Biotechnol 2007, 7:39.
128. Mena J., Ramirez O.T., Palomares L.A. Intracellular distribution of rotavirus structural proteins and virus-like particles expressed in the insect cell-baculovirus system. J Biotechnol 2006, 122:443-452.
129. Meyn M.A., Wilson M.B., Abdi F.A., Fahey N., Schiavone A.P., Wu J., et al. Src family kinases phosphorylate the Bcr-Abl SH3-SH2 region and modulate Bcr-Abl transforming activity. J Biol Chem 2006, 281:30907-30916.
130. Miyasaka T., Kaminogawa S., Shimizu M., Hisatsune T., Reinach P.S., Miyamoto Y. Characterization of human taurine transporter expressed in insect cells using a recombinant baculovirus. Protein Expr Purif 2001, 23:389-397.
131. Monsma S.A., Oomens A.G., Blissard G.W. The GP64 envelope fusion protein is an essential baculovirus protein required for cell-to-cell transmission of infection. J Virol 1996, 70:4607-4616.
132. Mortola E., Roy P. Efficient assembly and release of SARS coronavirus-like particles by a heterologous expression system. FEBS Lett 2004, 576:174-178.
133. Mulrooney P.M., Michalak T.I. Quantitative detection of hepadnavirus-infected lymphoid cells by in situ PCR combined with flow cytometry: implications for the study of occult virus persistence. J Virol 2003, 77:970-979.
134. Naggie S., Bentley W.E. Appearance of protease activities coincides with p10 and polyhedrin-driven protein production in the baculovirus expression system: effects on yield. Biotechnol Prog 1998, 14:227-232.
135. Nakajima M., Kato T., Kanamasa S., Park E.Y. Molecular chaperone-assisted production of human alpha-1,4-N-acetylglucosaminyltransferase in silkworm larvae using recombinant BmNPV bacmids. Mol Biotechnol 2009, 43:67-75.
136. Nelson K.L., Rogers J.A., Bowman T.L., Jove R., Smithgall T.E. Activation of STAT3 by the c-Fes protein-tyrosine kinase. J Biol Chem 1998, 273:7072-7077.
137. Noad R., Roy P. Virus-like particles as immunogens. Trends Microbiol 2003, 11:438-444.
138. Nobiron I., O'Reilly D.R., Olszewski J.A. Autographa californica nucleopolyhedrovirus infection of Spodoptera frugiperda cells: a global analysis of host gene regulation during infection, using a differential display approach. J Gen Virol 2003, 84:3029-3039.
139. O'Neal C.M., Crawford S.E., Estes M.K., Conner M.E. Rotavirus virus-like particles administered mucosally induce protective immunity. J Virol 1997, 71:8707-8717.
140. Overton H.A., Fujii Y., Price I.R., Jones I.M. The protease and gag gene products of the human immunodeficiency virus: authentic cleavage and post-translational modification in an insect cell expression system. Virology 1989, 170:107-116.
141. Palomares L.A., Lopez S., Ramirez O.T. Strategies for manipulating the relative concentration of recombinant rotavirus structural proteins during simultaneous production by insect cells. Biotechnol Bioeng 2002, 78:635-644.
142. Palomares L.A., Lopez S., Ramirez O.T. Multiplicity and time of infection to maximize virus-like particle production by insect cells. Animal cell technology: products from cells, cells as products 1999, 347-349. Kluwer Academic Publishers. A. Bernard (Ed.).
143. Park J.Y., Hun K., Hwang H.K., Lee S.J., Kim H.S., Hur B.K., et al. Large-scale production of rotavirus VLP as vaccine candidate using baculovirus expression vector system (BEVS). J Microbiol Biotechnol 2004, 14:35.
144. Peters K.L., Smithgall T.E. Tyrosine phosphorylation enhances the SH2 domain-binding activity of Bcr and inhibits Bcr interaction with 14-3-3 proteins. Cell Signal 1999, 11:507-514.
145. Possee R.D., Hitchman R.B., Richards K.S., Mann S.G., Siaterli E., Nixon C.P., et al. Generation of baculovirus vectors for the high-throughput production of proteins in insect cells. Biotechnol Bioeng 2008, 101:1115-1122.
146. Possee R.D., King L.A. Baculovirus transfer vectors. Methods Mol Biol 2007, 388:55-76.
147. Poul M.A., Cerutti M., Chaabihi H., Ticchioni M., Deramoudt F.X., Bernard A., et al. Cassette baculovirus vectors for the production of chimeric, humanized, or human antibodies in insect cells. Eur J Immunol 1995, 25:2005-2009.
148. Power J., Greenfield P.F., Nielsen L., Reid S. Modelling the growth and protein production by insect cells following infection by a recombinant baculovirus in suspension culture. Cytotechnology 1992, 9:149-155.
149. Power J.F., Reid S., Radford K.M., Greenfield P.F., Nielsen L.K. Modeling and optimization of the baculovirus expression vector system in batch suspension culture. Biotechnol Bioeng 1994, 44:710-719.
150. Prel A., Le Gall-Recule G., Cherbonnel M., Grasland B., Amelot M., Jestin V. Assessment of the protection afforded by triple baculovirus recombinant coexpressing H5, N3, M1 proteins against a homologous H5N3 low-pathogenicity avian influenza virus challenge in Muscovy ducks. Avian Dis 2007, 51:484-489.
151. Prel A., Le Gall-Recule G., Jestin V. Achievement of avian influenza virus-like particles that could be used as a subunit vaccine against low-pathogenic avian influenza strains in ducks. Avian Pathol 2008, 37:513-520.
152. Prikhod'ko G.G., Popham H.J.R., Felcetto T.J., Ostlind D.A., Warren V.A., Smith M.M., et al. Effects of simultaneous expression of Two sodium channel toxin genes on the properties of baculoviruses as biopesticides. Biol Control 1998, 12:66-78.
153. Pushko P., Tumpey T.M., Bu F., Knell J., Robinson R., Smith G. Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice. Vaccine 2005, 23:5751-5759.
154. Pushko P., Tumpey T.M., Van Hoeven N., Belser J.A., Robinson R., Nathan M., et al. Evaluation of influenza virus-like particles and Novasome adjuvant as candidate vaccine for avian influenza. Vaccine 2007, 25:4283-4290.
155. zu Putlitz J., Kubasek W.L., Duchene M., Marget M., von Specht B.U., Domdey H. Antibody production in baculovirus-infected insect cells. Nat Biotechnol 1990, 8:651-654.
156. Qian Y.M., Qiu W., Gao M., Westlake C.J., Cole S.P., Deeley R.G. Characterization of binding of leukotriene C4 by human multidrug resistance protein 1: evidence of differential interactions with NH2- and COOH-proximal halves of the protein. J Biol Chem 2001, 276:38636-38644.
157. Qin L., Zheng J., Grant C.E., Jia Z., Cole S.P., Deeley R.G. Residues responsible for the asymmetric function of the nucleotide binding domains of multidrug resistance protein 1. Biochemistry 2008, 47:13952-13965.
158. Quan F.S., Huang C., Compans R.W., Kang S.M. Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus. J Virol 2007, 81:3514-3524.
159. Rankin C., Ooi B.G., Miller L.K. Eight base pairs encompassing the transcriptional start point are the major determinant for baculovirus polyhedrin gene expression. Gene 1988, 70:39-49.
160. Robertson K.L., Verhoeven A.B., Thach D.C., Chang E.L. Monitoring viral RNA in infected cells with LNA flow-FISH. RNA 2010, 16:1679-1685.
161. Roldao A., Vieira H.L.A., Alves P.M., Oliveira R., Carrondo M.J.T. Intracellular dynamics in rotavirus-like particles production: evaluation of multigene and monocistronic infection strategies. Process Biochem 2006, 41:2188-2199.
162. Roldao A., Carrondo M.J.T., Alves P.M., Oliveira R. Stochastic simulation of protein expression in the baculovirus/insect cell system. Comput Chem Eng 2008, 32:68-77.
163. Roldao A., Vieira H.L.A., Charpilienne A., Poncet D., Roy P., Carrondo M.J.T., et al. Modeling rotavirus-like particles production in a baculovirus expression vector system: infection kinetics, baculovirus DNA replication, mRNA synthesis and protein production. J Biotechnol 2007, 128:875-894.
164. Sailaja G., Skountzou I., Quan F., Compans R.W., Kang S. Human immunodeficiency virus-like particles activate multiple types of immune cells. Virology 2007, 362:331-341.
165. Sanderson C.S., Barford J.P., Barton G.W., Wong T.K.K., Reid S. A structured, dynamic model for animal cell culture: application to baculovirus/insect cell systems. Biochem Eng J 1999, 3:219-229.
166. Schirrmann T., Al-Halabi L., Dubel S., Hust M. Production systems for recombinant antibodies. Front Biosci 2008, 13:4576-4594.
167. Schreiner S.J., Schiavone A.P., Smithgall T.E. Activation of STAT3 by the Src family kinase Hck requires a functional SH3 domain. J Biol Chem 2002, 277:45680-45687.
168. Schwarz D., Kisselev P., Honeck H., Cascorbi I., Schunck W.H., Roots I. Co-expression of human cytochrome P4501A1 (CYP1A1) variants and human NADPH-cytochrome P450 reductase in the baculovirus/insect cell system. Xenobiotica 2001, 31:345-356.
169. Shanks M., Lomonossoff G.P. Co-expression of the capsid proteins of Cowpea mosaic virus in insect cells leads to the formation of virus-like particles. J Gen Virol 2000, 81:3093-3097.
170. Shen X., Hu G.B., Jiang S.J., He F.R., Xing W., Li L., et al. Engineering and characterization of a baculovirus-expressed mouse/human chimeric antibody against transferrin receptor. Protein Eng Des Sel 2009, 22:723-731.
171. Shuler M.L., Kargi F. Bioprocess engineering: basic concepts 2002, Prentice Hall.
172. Silverton E.W., Navia M.A., Davies D.R. Three-dimensional structure of an intact human immunoglobulin. Proc Natl Acad Sci USA 1977, 74:5140-5144.
173. Smith C.K., Carr D., Mayhood T.W., Jin W., Gray K., Windsor W.T. Expression and purification of phosphorylated and non-phosphorylated human MEK1. Protein Expr Purif 2007, 52:446-456.
174. Smith I. Misleading messengers? Interpreting baculovirus transcriptional array profiles. J Virol 2007, 81:7819-7821.
175. Smith R.H., Levy J.R., Kotin R.M. A simplified baculovirus-AAV expression vector system coupled with one-step affinity purification yields high-titer rAAV stocks from insect cells. Mol Ther 2009, 17:1888-1896.
176. Sokolenko S., Cheng Y.L., Aucoin M.G. Getting more from cell size distributions: establishing more accurate biovolumes by estimating viable cell populations. Biotechnol Prog 2010, 26:1787-1795.
177. Solanas M., Moral R., Escrich E. Unsuitability of using ribosomal RNA as loading control for Northern blot analyses related to the imbalance between messenger and ribosomal RNA content in rat mammary tumors. Anal Biochem 2001, 288:99-102.
178. Song M., Park D.Y., Kim Y., Lee K.J., Lu Z., Ko K., et al. Characterization of N-glycan structures and biofunction of anti-colorectal cancer monoclonal antibody CO17-1A produced in baculovirus-insect cell expression system. J Biosci Bioeng 2010, 110:135-140.
179. Spanakis E. Problems related to the interpretation of autoradiographic data on gene expression using common constitutive transcripts as controls. Nucleic Acids Res 1993, 21:3809-3819.
180. Stowe R.P., Cubbage M.L., Sams C.F., Pierson D.L., Barrett A.D. Detection and quantification of Epstein-Barr virus EBER1 in EBV-infected cells by fluorescent in situ hybridization and flow cytometry. J Virol Methods 1998, 75:83-91.
181. Summers M.D. Milestones leading to the genetic engineering of baculoviruses as expression vector systems and viral pesticides. Insect viruses: biotechnological applications 2006, 3. Academic Press. B.C. Bonning, K. Maramorosch, A.J. Shatkin (Eds.).
182. Sun Y., Carrion R., Ye L., Wen Z., Ro Y.T., Brasky K., et al. Protection against lethal challenge by Ebola virus-like particles produced in insect cells. Virology 2009, 383:12-21.
183. Takehara K., Ireland D., Bishop D.H.L. Co-expression of the hepatitis B surface and core antigens using baculovirus multiple expression vectors. J Gen Virol 1988, 69:2763-2777.
184. Tamura S., Korzekwa K.R., Kimura S., Gelboin H.V., Gonzalez F.J. Baculovirus-mediated expression and functional characterization of human NADPH-P450 oxidoreductase. Arch Biochem Biophys 1992, 293:219-223.
185. Tate C.G., Whiteley E., Betenbaugh M.J. Molecular chaperones stimulate the functional expression of the cocaine-sensitive serotonin transporter. J Biol Chem 1999, 274:17551-17558.
186. Tatman J.D., Preston V.G., Nicholson P., Elliott R.M., Rixon F.J. Assembly of herpes simplex virus type 1 capsids using a panel of recombinant baculoviruses. J Gen Virol 1994, 75(Pt 5):1101-1113.
187. Thiem S.M., Miller L.K. Differential gene expression mediated by late, very late and hybrid baculovirus promoters. Gene 1990, 91:87-94.
188. Thomsen D.R., Meyer A.L., Post L.E. Expression of feline leukaemia virus gp85 and gag proteins and assembly into virus-like particles using the baculovirus expression vector system. J Gen Virol 1992, 73:1819-1824.
189. Thomsen D.R., Roof L.L., Homa F.L. Assembly of herpes simplex virus (HSV) intermediate capsids in insect cells infected with recombinant baculoviruses expressing HSV capsid proteins. J Virol 1994, 68:2442-2457.
190. Tomiya N., Betenbaugh M.J., Lee Y.C. Humanization of lepidopteran insect-cell-produced glycoproteins. Acc Chem Res 2003, 36:613-620.
191. Tomiya N., Howe D., Aumiller J.J., Pathak M., Park J., Palter K.B., et al. Complex-type biantennary N-glycans of recombinant human transferrin from Trichoplusia ni insect cells expressing mammalian [beta]-1,4-galactosyltransferase and [beta]-1,2-N-acetylglucosaminyltransferase II. Glycobiol 2003, 13:23-34.
192. Trowitzsch S., Bieniossek C., Nie Y., Garzoni F., Berger I. New baculovirus expression tools for recombinant protein complex production. J Struct Biol 2010, 172:45-54.
193. Tsao E.I., Mason M.R., Cacciuttolo M.A., Bowen S.H., Folena-Wasserman G. Production of parvovirus B19 vaccine in insect cells co-infected with double baculoviruses. Biotechnol Bioeng 1996, 49:130-138.
194. Urabe M., Ding C., Kotin R.M. Insect cells as a factory to produce adeno-associated virus type 2 vectors. Hum Gene Ther 2002, 13:1935-1943.
195. Urabe M., Nakakura T., Xin K., Obara Y., Mizukami H., Kume A., et al. Scalable generation of high-titer recombinant adeno-associated virus type 5 in insect cells. J Virol 2006, 80:1874-1885.
196. Urakawa T., Ferguson M., Minor P.D., Cooper J., Sullivan M., Almond J.W., et al. Synthesis of immunogenic, but non-infectious, poliovirus particles in insect cells by a baculovirus expression vector. J Gen Virol 1989, 70:1453-1463.
197. Vieira H.L.A., Estevao C., Roldao A., Peixoto C.C., Sousa M.F.Q., Cruz P.E., et al. Triple layered rotavirus VLP production: kinetics of vector replication, mRNA stability and recombinant protein production. J Biotechnol 2005, 120:72-82.
198. Volkman L.E., Goldsmith P.A. Mechanism of neutralization of budded Autographa californica nuclear polyhedrosis virus by a monoclonal antibody: inhibition of entry by adsorptive endocytosis. Virology 1985, 143:185-195.
199. Volpers C., Schirmacher P., Streek R.E., Sapp M. Assembly of the major and the minor capsid protein of human papillomavirus type 33 into virus-like particles and tubular structures in insect cells. Virology 1994, 200:504-512.
200. Wang B., Liu W., Kang S., Alam M., Huang C., Ye L., et al. Incorporation of high levels of chimeric human immunodeficiency virus envelope glycoproteins into virus-like particles. J Virol 2007, 81:10869-10878.
201. Wang X., Kelly D.C. Baculovirus replication: uptake of Trichoplusia ni nuclear polyhedrosis virus particles by insect cells. J Gen Virol 1985, 66:541-550.
202. Wang X.Z., Ooi B.G., Miller L.K. Baculovirus vectors for multiple gene expression and for occluded virus production. Gene 1991, 100:131-137.
203. Wang Z., Gerstein M., Snyder M. RNA-Seq a revolutionary tool for transcriptomics. Nat Rev Genet 2009, 10:57-63.
204. Wen Z., Pan L., Berenbaum M.R., Schuler M.A. Metabolism of linear and angular furanocoumarins by Papilio polyxenes CYP6B1 co-expressed with NADPH cytochrome P450 reductase. Insect Biochem Mol Biol 2003, 33:937-947.
205. Wen Z., Ye L., Gao Y., Pan L., Dong K., Bu Z., et al. Immunization by influenza virus-like particles protects aged mice against lethal influenza virus challenge. Antiviral Res 2009, 84:215-224.
206. Wickham T.J., Granados R.R., Wood H.A., Hammer D.A., Shuler M.L. General analysis of receptor-mediated viral attachment to cell surfaces. Biophys J 1990, 58:1501-1516.
207. Wong K.T., Peter C.H., Greenfield P.F., Reid S., Nielsen L.K. Low multiplicity infection of insect cells with a recombinant baculovirus: the cell yield concept. Biotechnol Bioeng 1996, 49:659-666.
208. Wong M.L., Medrano J.F. Real-time PCR for mRNA quantitation. Biotechniques 2005, 39:75-85.
209. Xie Z., Xie L., Pang Y., Lu Z., Xie Z., Sun J., et al. Development of a real-time multiplex PCR assay for detection of viral pathogens of penaeid shrimp. Arch Virol 2008, 153:2245-2251.
210. Xue J.L., Salem T.Z., Turney C.M., Cheng X.W. Strategy of the use of 28S rRNA as a housekeeping gene in real-time quantitative PCR analysis of gene transcription in insect cells infected by viruses. J Virol Methods 2010, 163:210-215.
211. Yamagishi J.I. DNA microarrays of baculovirus genomes: differential expression of viral genes in two susceptible insect cell lines. Arch Virol 2003, 148:587-597.
212. Yamshchikov G.V., Ritter G.D., Vey M., Compans R.W. Assembly of SIV virus-like particles containing envelope proteins using a baculovirus expression system. Virology 1995, 214:50-58.
213. Yang D.G., Chung Y.C., Lai Y.K., Lai C.W., Liu H.J., Hu Y.C. Avian influenza virus hemagglutinin display on baculovirus envelope: cytoplasmic domain affects virus properties and vaccine potential. Mol Ther 2007, 15:989-996.
214. Ye L., Lin J., Sun Y., Bennouna S., Lo M., Wu Q., et al. Ebola virus-like particles produced in insect cells exhibit dendritic cell stimulating activity and induce neutralizing antibodies. Virology 2006, 351:260-270.
215. Yokoyama N., Hirata M., Ohtsuka K., Nishiyama Y., Fujii K., Fujita M., et al. Co-expression of human chaperone Hsp 70 and Hsdj or Hsp40 co-factor increases solubility of overexpressed target proteins in insect cells. Biochim Biophys Acta 2000, 1493:119-124.
216. Zhang L., Wu G., Tate C.G., Lookene A., Olivecrona G. Calreticulin promotes folding/dimerization of human lipoprotein lipase expressed in insect cells (sf21). J Biol Chem 2003, 278:29344-29351.
217. Zhang Y., Turkson J., Carter-Su C., Smithgall T., Levitzki A., Kraker A., et al. Activation of Stat3 in v-Src-transformed fibroblasts requires cooperation of Jak1 kinase activity. J Biol Chem 2000, 275:24935-24944.
218. Zhou D., Linnenbach A.J., Liu R., Luzietti R.A., Harris J.J., Booth-Genthe C.L., et al. Expression and characterization of dog cytochrome P450 2A13 and 2A25 in baculovirus-infected insect cells. Drug Metab Dispos 2010, 38:1015-1018.